Bcl9-2, mutant is a peptide fragment incorporating targeted substitutions within a transcriptional co-regulator motif. The altered sequence reshapes its interaction surface, enabling dissection of binding hotspots and specificity determinants. The peptide is suited for structural and biophysical binding assays. Applications include protein-peptide interaction mapping and motif engineering.
CAT No: C08046
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More